Tag: NASDAQ:CGIX

November 20, 2019

Cancer Genetics Reports Q3 Financial Results

Cancer Genetics has reported its Q3 strategic, financial and operating results for the third quarter ended September 30, 2019.
August 20, 2019

Cancer Genetics Reports Q2 Financial Results

Cancer Genetics (NASDAQ:CGIX) has released its second quarter results for the quarter ended June 30, 2019. As quoted in the...
January 29, 2019

Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
December 17, 2018

Cancer Genetics Terminates Proposed Merger with NovellusDx

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
October 3, 2018

VIDEO — Life Science Update September 2018

With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...
September 18, 2018

Cancer Genetics Merges with NovellusDx

Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday.
September 18, 2018

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and...